28/07/2014 08:27:47 Free Membership Login

Mylan News (NASDAQ:MYL)

DateTimeSource
Headline
07/23/20147:00AMPRNUSMylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR
Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR District Court Judge Orders Apotex to Immediately Recall the Authorized Generic from its Direct Customers and to Stop Selling and Supplying the Product PR Newswire PITTSBURGH, July 23, 2014 PITTSBURGH, July 23, 2014 /PRNewswire/... More...>>
07/17/20147:00AMPRNUSMylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Ge...
Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product PR Newswire PITTSBURGH, July 17, 2014 PITTSBURGH, July 17, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey... More...>>
07/14/20146:35PMDJNMARKET SNAPSHOT: U.S. Stocks: Dow Closes Above 17,000
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks rebounded on Monday with the Dow Jones Industrial Average closing above 17,000 as a flurry of deal news and better-than-expected earnings from Citigroup Inc increased demand for equities. The banking heavyweight's profit topped estimates... More...>>
07/14/20146:34PMDJNMARKET SNAPSHOT: U.S. Stocks: Dow Closes Above 17,000
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks rebounded on Monday with the Dow Jones Industrial Average closing above 17,000 as a flurry of deal news and better-than-expected earnings from Citigroup Inc increased demand for equities. The banking heavyweight's profit topped estimates... More...>>
07/14/20146:30PMDJNMARKET SNAPSHOT: U.S. Stocks Rise On Earnings, M&A News
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks advanced, pushing the Dow Jones Industrial Average above 17,000 and its previous closing record on Monday as investors welcomed better-than-expected earnings from Citigroup Inc. and a flurry of mergers and acquisitions. The banking heavyweight's... More...>>
07/14/20146:24PMDJNMARKET SNAPSHOT: U.S. Stocks: Dow Tops 17,000, Eyes Record Close
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market gained, pushing the Dow Jones Industrial Average above 17,000 and its previous closing record on Monday as investors welcomed better-than-expected earnings from Citigroup Inc. and a flurry of mergers and acquisitions. The banking... More...>>
07/14/20146:23PMDJNMARKET SNAPSHOT: U.S. Stocks: Dow Tops 17,000 Again As Citi Rallies
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market gained, pushing the Dow Jones Industrial Average above 17,000 on Monday as investors welcomed better-than-expected earnings from Citigroup Inc. and a flurry of mergers and acquisitions. The banking heavyweight's profit topped... More...>>
07/14/20146:23PMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Monday's session are Citigroup Inc. (C), Riverbed Technology Inc. (RVBD) and Abbvie Inc. (ABBV). Citigroup said its second-quarter profit plunged 96% from a year earlier, as the bank took a large charge tied to a $7 billion deal the Justice Department to settle... More...>>
07/14/20146:23PMDJNMARKET SNAPSHOT: U.S. Stocks: Dow Tops 17,0000 Again As Citi Rallies
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market gained, pushing the Dow Jones Industrial Average above 17,000 on Monday as investors welcomed better-than-expected earnings from Citigroup Inc. and a flurry of mergers and acquisitions. The banking heavyweight's profit topped... More...>>
07/14/20146:21PMDJNAbbott Flees Struggling Business to Explore New Deals -- Market Talk
1330 GMT By selling its mature-market branded generics unit to Mylan (MYL) for $5.3 billion in stock, Abbott (ABT) will dump a business that has been a drag on its sales and earnings growth, Bernstein says. Abbott has struggled to revitalize the generics business, which declined 4% last year, in the face of downward pricing... More...>>
07/14/20146:20PMDJNMARKET SNAPSHOT: U.S. Stocks: Futures Climb; Citigroup Results In View
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- U.S. stock futures pointed higher Monday as a flurry of merger news and better-than-expected earnings from Citigroup Inc. lifted investor sentiment. The banking heavyweight's profit topped estimates, while it also reached a $7 billion settlement... More...>>
07/14/20146:18PMDJNMARKET SNAPSHOT: U.S. Stocks: Futures Climb; Citigroup Results In View
By Anora Mahmudova and Carla Mozee, MarketWatch NEW YORK (MarketWatch) -- U.S. stock futures pointed higher Monday as a flurry of merger news and upbeat earnings from Citigroup Inc. lifted investor sentiment. The banking heavyweight's profit topped estimates, while it also reached a $7 billion settlement with the U.S... More...>>
07/14/20142:11PMDJNMARKET SNAPSHOT: U.S. Stocks: Futures Climb; Citigroup Results In View
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.S. stock futures pointed higher Monday, with shares of Citigroup Inc. up in premarket trade after the banking heavyweight unveiled a $7 billion settlement with the U.S. Justice Department ahead of its quarterly financial results. Futures for the Dow Jones Industrial... More...>>
07/14/20146:30AMPRNUSMylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction PR Newswire PITTSBURGH, July 14, 2014 - Brings Differentiated, Attractive Product Portfolio and Enhanced Commercial Platform, Diversifying Mylan's Business and Adding New Sales Channels in Acquired Markets... More...>>
07/14/20146:30AMPRNUSMylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction Brings Differentiated, Attractive Product Portfolio and Enhanced Commercial Platform, Diversifying Mylan's Business and Adding New Sales Channels in Acquired Markets Immediately and Significantly Accretive... More...>>
07/08/20147:30AMPRNUSMylan Launches Generic Micardis® Tablets
Mylan Launches Generic Micardis® Tablets PR Newswire PITTSBURGH, July 8, 2014 PITTSBURGH, July 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Telmisartan Tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis® Tablets. Mylan received final approval... More...>>
07/01/20141:02PMPRNUSMylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014
Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014 Mylan to Host Investor Day on Sept. 18, 2014 PR Newswire PITTSBURGH, July 1, 2014 PITTSBURGH, July 1, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced today that it will host a conference call and live webcast... More...>>
06/11/201411:49AMPRNUSMylan Launches Generic Actonel® Tablets, 150 mg
Mylan Launches Generic Actonel® Tablets, 150 mg PR Newswire PITTSBURGH, June 11, 2014 PITTSBURGH, June 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott's Actonel® Tablets. Mylan received final approval... More...>>
06/09/20147:30AMPRNUSMylan Launches Generic Paraplatin® Injection
Mylan Launches Generic Paraplatin® Injection PR Newswire PITTSBURGH, June 9, 2014 PITTSBURGH, June 9, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Carboplatin Injection, 50 mg/5 ml, in multi-dose vials, which is the generic version of Bristol-Myers Squibb's Paraplatin® Injection... More...>>
06/05/20148:45AMPRNUSMylan to Present at the Goldman Sachs 35th Annual Global HealthCare Conference
Mylan to Present at the Goldman Sachs 35th Annual Global HealthCare Conference PR Newswire PITTSBURGH, June 5, 2014 PITTSBURGH, June 5, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that the company will present at the Goldman Sachs... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq myl140728 08:27